FUNDAMENTALS
EdgeFII/DII
MOLBIOMolbio Diagnostics Ltd
₹1,495.50-2.02%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
MOLBIONSE · EquityHealthcare

Molbio Diagnostics Ltd

ISIN
INE869T01028
Instrument key
NSE_EQ|INE869T01028
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹1,495.50-30.90 · -2.02%
Day rangecircuit ₹1,196.40 – ₹1,794.60
1,483.10
1,580.00

as of 21/11/2026, 1:13:19 pm

Open
₹1,549.80
Day high
₹1,580.00
Day low
₹1,483.10
Prev. close
₹1,526.40
Volume
7.01 L
VWAP
₹1,530.99

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

1 week · 15-minute candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M
6M
1Y
5Y
MAX
Change · 1W
-1.15%
1,512.40 → 1,495.00
Period high
₹1,580.00
20/11/2026
Period low
₹1,458.00
18/11/2026
From high
-5.38%
+2.54% from low
Avg volume
20.6K
25.75 L total
Candles
125
58 up / 64 down
20 Nov 2026O 1,497.30H 1,499.10L 1,487.00C 1,495.00Vol 48.8K
SMA 20SMA 50Averages need 50 candles before they begin
Candle data125 rows of open, high, low, close and volumeShowHide
20 Nov 20261,497.301,499.101,487.001,495.00-0.15%12.1048.8K
20 Nov 20261,513.001,513.301,483.101,497.60-1.02%30.2040.8K
20 Nov 20261,514.701,515.401,505.001,512.50-0.15%10.4017.2K
20 Nov 20261,512.701,522.001,510.201,515.20+0.17%11.8017.4K
20 Nov 20261,507.001,514.701,506.001,512.40+0.36%8.7016.7K
20 Nov 20261,506.901,508.001,505.001,506.900.00%3.003.9K
20 Nov 20261,509.001,510.001,506.101,507.10-0.13%3.907.3K
20 Nov 20261,503.501,512.901,500.901,509.70+0.41%12.007.4K
20 Nov 20261,505.801,506.401,502.101,503.40-0.16%4.302.9K
20 Nov 20261,503.901,507.401,503.701,505.90+0.13%3.702.7K

Historical price and volume data · Showing 1–10 of 125

1 / 13

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

121.64
Company
121.64
Sector
39.99

Worse than sector by 204%

P/B

Price ÷ book value per share

11.96
Company
11.96
Sector
4.0

Worse than sector by 199%

ROA

Net income ÷ total assets

6.08%
Company
6.08%
Sector
10.51%

Worse than sector by 42%

ROE

Net income ÷ shareholders' equity

10.72%
Company
10.72%
Sector
17.51%

Worse than sector by 39%

ROCE

EBIT ÷ capital employed

13.62%
Company
13.62%
Sector
18.73%

Worse than sector by 27%

Quick Ratio

Liquid assets ÷ current liabilities

1.68
Company
1.68
Sector
2.72

Worse than sector by 38%

EV/EBITDA

Enterprise value ÷ EBITDA

53.01
Company
53.01
Sector
14.77

Worse than sector by 259%

04/Business

About the company

Sector: Healthcare

Sector market cap (INR)
₹17,228 Cr

reported in crore

Sector market cap (USD)
$1.91B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Consolidated income statement

Quarterly figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Sep 2026
₹265 Cr
-35.65% vs Jun 2026
Net profit · Sep 2026
₹8 Cr
-85.40% vs Jun 2026
Operating margin
6.6%
was 18.4%
Revenue CAGR · 4p
-23.1%
profit -58.4% · op -50.9%
Filed order
Revenue265411565581
Revenue growthreported-35.6%-27.2%-2.7%—
Operating profit1876132148
Operating profit growthreported-76.9%-42.4%-10.8%—
Operating marginderived6.6%18.4%23.3%25.4%
Net profit85396107
Net profit growthreported-85.4%-45.0%-10.3%—
Net marginderived2.9%12.8%16.9%18.4%
EPS — basic₹/share, annual——14.77—

Figures in ₹ crore. Margin rows are computed from the reported values.

06/Balance sheet

Consolidated balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹2,148 Cr
+46.99% YoY
Total liabilities
₹840 Cr
Net worth
₹1,309 Cr
Liabilities ÷ assets
39.1%
lower means a lighter balance sheet
Filed order
Total assets2,1481,4621,2211,034
Total liabilities840494392297
Net worthderived1,309967829737
Liabilities ÷ assetsderived39.1%33.8%32.1%28.7%
Asset growthderived47.0%19.7%18.1%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets764532398423
Current Assets1,385930823611
Total Assets2,1481,4621,2211,034
Current Liabilities557442343258
Net Current Asset827488480354
Non-Current Liabilities282534939
Equity Capital1,309967829737
Total Equity & Liabilities2,1481,4621,2211,034

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Consolidated cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹50 Cr
-82.45% YoY
Investing
-₹93 Cr
Financing
₹276 Cr
Free cash flow
-₹43 Cr
operating + investing
Filed order
Operating activities502871064
Operating changereported-82.5%2900.0%-85.1%—
Investing activities-93-123-45-40
Investing changereported24.0%-172.5%-13.3%—
Financing activities276-26-3218
Financing changereported1155.7%17.1%-273.0%—
Net cash flowderived233138-6743
Free cash flowoperating + investing-43164-3524

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax23119413010
Income before WC changes35328527347
Change in Assets-257-55-25220
Change in Liabilities251373235
Change in WC-23282-22055
Cash flow from Operations502871064
Cash flow from Investing-93-123-45-40
Cash flow from Financing276-26-3218
Total Cash Flow233138-6743
Cash (Start of the year)63-75-8-51
Cash (End of the year)33663-75-8

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 3 reported quarters. Sort any quarter column to rank holders by size.

Promoters
41.29%
0.00 pts QoQ
FII
1.59%
+0.08 pts QoQ
DII (other)
11.06%
-3.06 pts QoQ
Mutual funds
8.03%
+5.78 pts QoQ
Retail & others
38.03%
-2.79 pts QoQ
Filed order
Promoters41.3%41.3%46.6%
FII1.6%1.5%0.0%
DII (other)11.1%14.1%0.0%
Mutual funds8.0%2.3%0.0%
Retail & others38.0%40.8%53.4%
Promoters — QoQ changepts, derived0.0%-5.4%—
FII — QoQ changepts, derived0.1%1.5%—
DII (other) — QoQ changepts, derived-3.1%14.1%—
Mutual funds — QoQ changepts, derived5.8%2.3%—
Retail & others — QoQ changepts, derived-2.8%-12.5%—
Totalderived100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

No corporate actions on record

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.

Full annual line itemsRevenue, other income, expenses, tax, EPS
ShowHide
Filed order
Revenue1,4461,020837332
Other Income9845
Total Revenue1,4551,028841337
Total Expenses1,221820658328
Profit Before Tax23119413010
Tax67564613
Profit After Tax16413984-3
EPS - Basic14.7712.879.05-0.06
EPS - Diluted14.7712.879.04-0.06

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.